4.7 Article

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer?s disease using multimodal data

期刊

出版社

ELSEVIER
DOI: 10.1016/j.csbj.2022.08.007

关键词

Alzheimer?s disease; Mild cognitive impairment; Decision trees

资金

  1. Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  2. [20K15778]
  3. [JP20dk0207045]
  4. [JP20ek0109392]
  5. [JP20dm0207073]
  6. [JP22wm0525019]
  7. [JP22dk0207060]

向作者/读者索取更多资源

In this study, a model was developed to subtypes individuals with mild cognitive impairment (MCI) and predict their conversion to Alzheimer's disease (AD), and the underlying biological characteristics of each subtype were analyzed. Based on different levels of abnormality in cerebrospinal fluid (CSF) biomarkers, brain atrophy, and cognitive decline, MCI was classified into five subtypes, further categorized into three groups based on their conversion rates to AD. The identified subtypes showed varying conversion rates and biological profiles.
Mild cognitive impairment (MCI) is a high-risk condition for conversion to Alzheimer's disease (AD) dementia. However, individuals with MCI show heterogeneous patterns of pathology and conversion to AD dementia. Thus, detailed subtyping of MCI subjects and accurate prediction of the patients in whom MCI will convert to AD dementia is critical for identifying at-risk populations and the underlying biolog-ical features. To this end, we developed a model that simultaneously subtypes MCI subjects and predicts conversion to AD and performed an analysis of the underlying biological characteristics of each subtype. In particular, a heterogeneous mixture learning (HML) method was used to build a decision tree-based model based on multimodal data, including cerebrospinal fluid (CSF) biomarker data, structural magnetic resonance imaging (MRI) data, APOE genotype data, and age at examination. The HML model showed an average F1 score of 0.721, which was comparable to the random forest method and had significantly more predictive accuracy than the CART method. The HML-generated decision tree was also used to classify-five subtypes of MCI. Each MCI subtype was characterized in terms of the degree of abnormality in CSF biomarkers, brain atrophy, and cognitive decline. The five subtypes of MCI were further catego-rized into three groups: one subtype with low conversion rates (similar to cognitively normal subjects); three subtypes with moderate conversion rates; and one subtype with high conversion rates (similar to AD dementia patients). The subtypes with moderate conversion rates were subsequently separated into a group with CSF biomarker abnormalities and a group with brain atrophy. The subtypes identified in this study exhibited varying MCI-to-AD conversion rates and differing biological profiles.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-commons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据